Martin Christopher Nathan bought ORKA
December 11, 2025 · Form 4 insider transaction
Martin Christopher Nathan bought 35,000 shares of Oruka Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
35,000
Price
$0.00
Total value
N/A
InsiderMartin Christopher Nathan
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateDecember 11, 2025
Filing dateDecember 11, 2025
Shares owned after35,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests as to 1/36 of the underlying shares monthly from December 11, 2025.